US Patent Issued to Multitude Therapeutics on Dec. 16 for "CD142 antibodies, antibody-drug conjugates, preparations and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,354, issued on Dec. 16, was assigned to Multitude Therapeutics Inc. (Shanghai).

"CD142 antibodies, antibody-drug conjugates, preparations and uses thereof" was invented by Xun Meng (Shanghai), Shu-Hui Liu (Redwood City, Calif.) and Yue Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the antibodies specific targeting CD142, antibody-drug conjugates, preparations and uses thereof. The antibody or antigen-binding fragment thereof binding to CD142 is covalently linked to a cytotoxic payload through a linker. The antibody or antigen-binding fragment thereof binding to CD142 and the antibody-drug conjugate ...